Demystifying Moderna: Insights From 16 Analyst Reviews
Media

Demystifying Moderna: Insights From 16 Analyst Reviews

Latest Ratings for MRNA

Date Firm Action From To
Mar 2022 Deutsche Bank Maintains Hold
Feb 2022 Morgan Stanley Maintains Equal-Weight
Feb 2022 SVB Leerink Maintains Underperform

View More Analyst Ratings for MRNA

View the Latest Analyst Ratings

read more

​ 

​Latest Ratings for MRNA
DateFirmActionFromTo Mar 2022Deutsche BankMaintainsHold Feb 2022Morgan StanleyMaintainsEqual-Weight Feb 2022SVB LeerinkMaintainsUnderperform
View More Analyst Ratings for MRNA

View the Latest Analyst Ratings

read more 

Leave a Reply

Your email address will not be published. Required fields are marked *

This material is for informational purposes is not intended to be relied upon as a forecast, research or investment advice, and is not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy. The opinions expressed are as of date of publication and are subject to change. Reliance upon information in this material is at the sole discretion of the reader. Past performance is not indicative of current or future results. This information provided is neither tax nor legal advice and investors should consult with their own advisors before making investment decisions. Investment involves risk including possible loss of principal.